8.57
-0.41
(-4.57%)
At close: January 10 at 4:00:01 PM EST
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-39,924.00
-33,336.00
-26,199.00
-15,283.00
-330.00
Investing Cash Flow
43,780.00
-54,100.00
-84,688.00
-104.00
--
Financing Cash Flow
-286.00
-204.00
--
286,447.00
5,500.00
End Cash Position
90,009.00
78,420.00
165,955.00
276,776.00
5,895.00
Capital Expenditure
-48.00
-100.00
-67.00
-104.00
-21.00
Issuance of Capital Stock
--
15.00
--
309,200.00
5,500.00
Repayment of Debt
-301.00
-219.00
--
--
--
Free Cash Flow
-39,972.00
-33,436.00
-26,266.00
-15,387.00
-330.00
12/31/2020 - 6/25/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
CYBN Cybin Inc.
8.89
-7.01%
MLYS Mineralys Therapeutics, Inc.
9.87
-11.87%
CRGX CARGO Therapeutics, Inc.
13.50
-4.93%
ATAI Atai Life Sciences N.V.
1.5000
-7.41%
LSTA Lisata Therapeutics, Inc.
3.7300
-1.84%
MGTX MeiraGTx Holdings plc
6.20
-2.36%
BCAX Bicara Therapeutics Inc.
14.38
-5.70%
DYN Dyne Therapeutics, Inc.
15.87
-31.15%
ABVX ABIVAX Société Anonyme
6.38
-4.49%
VYNE VYNE Therapeutics Inc.
3.4300
-12.50%